MUST READ! New Research Indicates That Certain Nutraceuticals Could Help In Both Influenza And Coronavirus Infections
必讀！ 最新研究表明，某些營養保健品可能有助於流感和冠狀病毒感染
A new published research by Dr Mark McCarty of the Catalytic Longevity Foundation, San Diego, CA, USA, and Dr James DiNicolantonio, PharmD, a cardiovascular research scientist at Saint Luke's Mid America Heart Institute, Kansas City, MO, USA, proposes that certain nutraceutical supplements may help provide relief to people infected with encapsulated RNA viruses such as influenza and coronavirus.
The study identified that nutraceuticals such as Alpha-Lipoic Acid, N-Acetycysteine, Glucosamine, Selenium, Ferilic Acid, Yeast Beta –Glucan and also Selenium could help alleviate certain symptoms in those diseases and also help boost natural antiviral activity of the body by type I interferon.
美 國加利福尼亞州聖地亞哥市催化長壽基金會的Mark McCarty博士和美國密蘇里州堪薩斯城聖盧克中,美洲心臟研究所的心血管研究科學家James DiNicolantonio博士進行了一項新發表的研究。營養保健品補充劑可能有助於緩解感染諸如流感和冠狀病毒等封裝的RNA病毒的人。
研究發現，諸如啤酒酵母Liotic®α-硫辛酸，N-乙酰半胱氨酸，葡糖胺，硒，阿魏酸，酵母β-葡聚醣以及硒等營養品可以幫助緩解這些疾病中的某些症狀，並且還可以幫助提高人體天然抗病毒活性我干擾素。
In America alone, influenza infects around 32 million people every year causing around 32,000 deaths, while the global numbers are exponentially higher.
Though there are drugs and pharmaceuticals approved for the treatment of influenza, they typically are expensive with lots of side effects, and are not very effective. Additionally, vaccinations against influenza may only be effective in around 60 percent of those vaccinated. Thus, there is a need for safer and effective alternatives in those infected with influenza.
In the last few weeks, a novel RNA coronavirus, now called SARS-Cov-2 that caused the COVID-19, has broken out in China and has spread to over 32 countries and infected more than 80,000 people causing more than 2,700 deaths.
僅在美國，流感每年感染約3200萬人，造成約32,000人死亡，而全球的數字則成倍增加。
儘管已經批准了用於治療流感的藥物，但它們通常很昂貴，並且副作用很多，效果不是很好。此外，針對流感的疫苗接種可能僅對約60％的疫苗有效。因此，在感染流感的人中需要一種更安全有效的替代品。
在過去的幾周中，一種新的RNA冠狀病毒（現在稱為SARS-Cov-2）引起了COVID-19，該病毒已在中國爆發，並已擴散到32個國家，感染了80,000多人，造成2700多人死亡。
In reality, this new coronavirus is much more lethal than the typical flu, with a current mortality rate of about 2.92 percent. In other words, around 1 in 33 people who are infected with this novel coronavirus will die. Whereas the annual flu has a mortality rate of just 0.05 to 0.1 percent. This means that around 1 in 1,000 to 2,000 people infected with the annual flu will die.
In other words, the new coronavirus is around 30 to 60 times more lethal than the typical annual flu.( strangely many health authorities are trying to downplay the seriousness of this new coronavirus especially China)
It has been observed and clinically proven that both influenza and coronavirus cause an inflammatory storm in the lungs and it is this inflammatory storm that leads to acute respiratory distress, organ failure, and death.
實際上，這種新的冠狀病毒比典型的流感更具致命性，目前的死亡率約為2.92％。 換句話說，感染這種新型冠狀病毒的33人中約有1人會死亡。 而年度流感的死亡率僅為0.05％至0.1％。 這意味著，每年感染流感的1,000至2,000人中約有1人將死亡。
換句話說，新的冠狀病毒的致死性比典型的年度流感高出30到60倍（奇怪的是，許多衛生當局都在輕視這種新的冠狀病毒的嚴重性，尤其是中國）
已經觀察到並臨床證明，流感和冠狀病毒均引起肺部炎性風暴，正是這種炎性風暴導致急性呼吸窘迫，器官衰竭和死亡。
Certain nutraceutical suppements may help to reduce the inflammation in the lungs from RNA viruses and others may also help boost type 1 interferon response to these viruses, which is the body's primary way to help create antiviral antibodies to fight off viral infections.
The medical researchers drew attention to several randomized clinical studies in humans that have found that over the counter supplements such as n-acetylcysteine (NAC), which is used to treat acetaminophen poisoning and is also used as a mucus thinner to help reduce bronchitis exacerbations, and elderberry extracts, have evidence for shortening the duration of influenza by about two to four days and reducing the severity of the infection.
The medical researchers also note several nutraceuticals such beta-glucan, glucosamine, and NAC have either been found to reduce the severity of infection or to cut the rate of death in half in animals infected with influenza.
某些營養補充品可能有助於減少RNA病毒引起的肺部炎症，其他營養補充品也可能有助於增強對這些病毒的1型乾擾素反應，這是人體創建抗病毒抗體以抵抗病毒感染的主要方法。
醫學研究人員提請注意一些針對人體的隨機臨床研究，這些研究發現，非處方補充劑（例如n-乙酰半胱氨酸（NAC））可用於治療對乙酰氨基酚中毒，還可以用作稀釋劑以幫助減少支氣管炎加重， 和接骨木提取物的證據表明，流感持續時間縮短了約兩到四天，並降低了感染的嚴重程度。
醫學研究人員還注意到，已經發現幾種營養品，例如β-葡聚醣，葡萄糖胺和NAC，可以降低感染流感的動物的嚴重程度或將死亡率降低一半。
Dr. DiNicolantonio told Thailand Medical News, "Therefore, it is clear that certain nutraceuticals have antiviral effects in both human and animal studies. Considering that there is no treatment for the new coronavirus that causes the deadly Covid-19 disease and treatments for influenza are limited, we welcome further studies to test these nutraceuticals as a strategy to help provide relief in those infected with encapsulated RNA viruses."
Thailand Medical News also advises readers that when buying nutraceuticals and supplements, to do due diligence as many supplements brands carry product lines containing ingredients that are not really bioactive, not properly absorbable and sometimes mislead consumers by having the wrong isomer forms or chemical forms of the ingredients that are of no use. Even worst in some cases, the might have either minute or no traces of the active ingredients and might contain certain dangerous contaminants. Most supplements are not properly regulated and monitored by health and regulatory agencies. It best to avoid all Asian manufactured brands especially those made in countries like Myanmar, Vietnam, Indonesia. Always stick to brands made in Canada, US and Germany.
DiNicolantonio博士對《泰國醫學新聞》說：“因此，很明顯某些保健食品在人類和動物研究中均具有抗病毒作用。考慮到目前尚無可導致致命Covid-19疾病的新型冠狀病毒的治療方法和流感治療方法，在有限的範圍內，我們歡迎進行進一步的研究以測試這些營養保健品，以此作為緩解被封裝RNA病毒感染者緩解症狀的一種策略。”
《泰國醫學新聞》還建議讀者，在購買營養保健品和補品時，要進行盡職調查，因為許多補品品牌的產品線所含成分並非真正具有生物活性，不能正確吸收，有時會因錯誤的異構體形式或化學形式而誤導消費者。沒有用的成分。在某些情況下甚至更糟的是，其中的活性成分可能很少或根本沒有痕跡，並且可能包含某些危險的污染物。大多數補品沒有得到衛生和監管機構的適當監管。最好避免所有亞洲製造的品牌，尤其是那些在緬甸，越南，印度尼西亞等國家製造的品牌。始終堅持加拿大，美國和德國製造的品牌。
For the latest coronavirus research, keep checking : https://www.thailandmedical.news/articles/coronavirus
Main Study Reference : Mark F. McCarty et al, Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus, Progress in Cardiovascular Diseases (2020). DOI: 10.1016/j.pcad.2020.02.007
資料來源: https://bit.ly/3aIQomE
留言列表
